Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research

The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Litty, Duschl, Albert, Himly, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349961/
https://www.ncbi.nlm.nih.gov/pubmed/32443671
http://dx.doi.org/10.3390/vaccines8020237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349961/
https://www.ncbi.nlm.nih.gov/pubmed/32443671
http://dx.doi.org/10.3390/vaccines8020237

Ejemplares similares